Table 3.
Impact of CMR on patient management | n |
---|---|
Impact on revascularization | 10 |
ȃLed to PCI/CABG | 6 |
ȃAvoided PCI/CABG | 4 |
Impact on medications | 8 |
ȃStarted anticoagulation | 1 |
ȃStopped anticoagulation | 2 |
ȃStarted immunosuppressive therapy | 4 |
ȃStarted ASA/statin | 1 |
Impact on diagnostics | 13 |
ȃLed to genetic testing | 9 |
ȃLed to endomyocardial biopsy | 4 |
Impact on electrophysiology procedures | 20 |
ȃAvoided ablation | 3 |
ȃChange in ablation approach | 17 |
TOTAL | 51 |